Wachtell, Lipton, Rosen & Katz advises boards of directors and senior executives on executive compensation issues within the context of M&A, divestitures, and complex corporate transactions. The firm handles a wide range of corporate governance challenges, including those posed by shareholder activists, proxy battles, and executive succession planning. Leading the New York-based team, Jeannemarie O’Brien is acclaimed for her executive compensation and benefits expertise in transactions involving financial services firms. Adam Shapiro and David Kahan focus on M&A, corporate governance, and executive employment agreements. Michael Schobel has a broad industry reach, with significant experience in banking, finance, technology, and pharmaceuticals, including his notable role in Pfizer’s $43 billion acquisition of Seagen. Erica Bonnett offers guidance on securities law compliance, compensation disclosures, and the structuring of executive employment contracts.
Legal 500 redaktioneller Kommentar
- Profil
Kernmandanten
- Pfizer
- FIS
- Arconic Corporation
- National Instruments
- Stone Point Capital, Warburg Pincus, Reverence Capital Partners, Sixth Street and Bayview Asset Management
- Capri Holdings
- American International Group
- CIGNA
- MDU Resources Group
- Prologis
Anwält*innen
Hall of fame
Die Anwält*innen an der Spitze ihres Berufsstands, die aufgrund ihres langjährigen Engagements in marktführender Arbeit von Wettbewerbern und Mandanten gleichermaßen geschätzt und anerkannt werden.
Adam Shapiro
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Michael Schobel
Praxisleitung
Jeannemarie O’Brien
Weitere Kernanwält*innen
Adam Shapiro; David Kahan; Michael Schobel; Erica Bonnett